67
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES

Massive coronary perforation and shock: From appropriate labeling to appropriate calls

, , , &
Pages 181-186 | Received 25 Nov 2008, Published online: 08 Oct 2009

References

  • Gunning MG, Williams IL, Jewitt DE, Shah AM, Wainwright RJ, Thomas MR. Coronary artery perforation during percutaneous intervention: incidence and outcome. Heart. 2002; 88: 495–8
  • Witzke CF, Martin-Herrero F, Clarke SC, Pomerantzev E, Palacios IF. The changing pattern of coronary perforation during percutaneous coronary intervention in the new device era. J Invasive Cardiol. 2004; 16: 257–301
  • Lansky AJ, Yang YM, Khan Y, Costa RA, Pietras C, Tsuchiya Y, et al. Treatment of coronary artery perforations complicating percutaneous coronary intervention with a polytetrafluoroethylene-covered stent graft. Am J Cardiol. 2006; 98: 370–4
  • Ajluni SC, Glazier S, Blankenship L, O'Neill WW, Safian RD. Perforations after percutaneous coronary interventions: clinical, angiographic, and therapeutic observations. Cathet Cardiovasc Diagn. 1994; 32: 206–12
  • Ramana RK, Arab D, Joyal D, Steen L, Cho L, Lewis B, et al. Coronary artery perforation during percutaneous coronary intervention: incidence and outcomes in the new interventional era. J Invasive Cardiol. 2005; 17: 603–5
  • Holmes DR, Jr, Mehta S, George CJ, Margolis JR, Leon MB, Isner JM, et al. Excimer laser coronary angioplasty: The new approaches to coronary intervention (NACI) experience. Am J Cardiol. 1997; 80: 99K–105K
  • Ellis SG, Ajluni S, Arnold AZ, Popma JJ, Bittl JA, Eigler NL, et al. Increased coronary perforation in the new device era. Incidence, classification, management, and outcome. Circulation. 1994; 90: 2725–30
  • Fasseas P, Orford JL, Panetta CJ, Bell MR, Denktas AE, Lennon RJ, et al. Incidence, correlates, management, and clinical outcome of coronary perforation: Analysis of 16,298 procedures. Am Heart J. 2004; 147: 140–5
  • Von Sohsten R, Kopistansky C, Cohen M, Kussmaul WG 3rd. Cardiac tamponade in the ‘new device’ era: evaluation of 6999 consecutive percutaneous coronary interventions. Am Heart J. 2000; 140: 279–83
  • Dippel EJ, Kereiakes DJ, Tramuta DA, Broderick TM, Shimshak TM, Roth EM, et al. Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade: an algorithm for percutaneous management. Catheter Cardiovasc Interv. 2001; 52: 279–86
  • Briguori C, Nishida T, Anzuini A, Di Mario C, Grube E, Colombo A. Emergency polytetrafluoroethylene-covered stent implantation to treat coronary ruptures. Circulation. 2000; 102: 3028–31
  • Ly H, Awaida JP, Lespérance J, Bilodeau L. Angiographic and clinical outcomes of polytetrafluoroethylene-covered stent use in significant coronary perforations. Am J Cardiol. 2005; 95: 244–6
  • Javaid A, Buch AN, Satler LF, Kent KM, Suddath WO, Lindsay J, Jr, et al. Management and outcomes of coronary artery perforation during percutaneous coronary intervention. Am J Cardiol. 2006; 98: 911–4
  • Gercken U, Lansky AJ, Buellesfeld L, Desai K, Badereldin M, Mueller R, et al. Results of the Jostent coronary stent graft implantation in various clinical settings: procedural and follow-up results. Catheter Cardiovasc Interv. 2002; 56: 353–60
  • Stankovic G, Colombo A, Presbitero P, van den Branden F, Inglese L, Cernigliaro C, et al. Randomized Evaluation of polytetrafluoroethylene covered stent in saphenous vein grafts investigators. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: The randomized evaluation of polytetrafluoroethylene covered stent in saphenous vein grafts (RECOVERS) trial. Circulation. 2003; 108: 37–42
  • Schächinger V, Hamm CW, Münzel T, Haude M, Baldus S, Grube E, et al. STENTS (stents in grafts) investigators. A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts. J Am Coll Cardiol. 003; 42: 1360–9
  • Laarman GJ, Kiemeneij F, Mueller R, Guagliumi G, Cobaugh M, Serruys PW. symbiot II trial investigators. Feasibility, safety, and preliminary efficacy of a novel ePTFE-covered self-expanding stent in saphenous vein graft lesions: The symbiot II trial. Catheter Cardiovasc Interv. 2005; 64: 361–8
  • Lenti M, Cieri E, De Rango P, Pozzilli P, Coscarella C, Bertoglio C, et al. Endovascular treatment of long lesions of the superficial femoral artery: results from a multicenter registry of a spiral, covered polytetrafluoroethylene stent. J Vasc Surg. 2007; 45: 32–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.